SCHEMBL12175482

SCHEMBL12175482

Cn1cc(P(=S)(c2ccccc2)c2ccccc2)c2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 7/20 1.00
GPR84 Q9NQS5 1/20 0.46
ALDH1A1 P00352 4/20 0.43
IMPDH2 P12268 2/20 0.43
POLB P06746 1/20 0.42
KDM4E B2RXH2 4/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 2/20 0.42
LMNA P02545 2/20 0.42
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
NPC1 O15118 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12175523 0.81 NPSR1 (0.68) NPSR1GPR84ALDH1A1IMPDH2POLB
SCHEMBL27249951 0.74 NPSR1 (0.59) NPSR1GPR84ALDH1A1IMPDH2POLB
SCHEMBL2589910 0.68 NPSR1 (0.59) NPSR1ALDH1A1POLBKDM4ERAB9A
SCHEMBL2595693 0.68 NPSR1 (1.00) NPSR1ALDH1A1KDM4ERAB9AMAPT
SCHEMBL146530 0.66 GPR84 (0.57) NPSR1GPR84ALDH1A1IMPDH2POLB
SCHEMBL21035552 0.66 GPR84 (0.57) NPSR1GPR84ALDH1A1IMPDH2POLB
SCHEMBL10395712 0.66 GPR84 (0.57) NPSR1GPR84ALDH1A1IMPDH2POLB
SCHEMBL29473770 0.66 GPR84 (0.57) NPSR1GPR84ALDH1A1IMPDH2POLB
SCHEMBL11124013 0.66 GPR84 (0.52) NPSR1GPR84ALDH1A1IMPDH2POLB
SCHEMBL1310255 0.66 IMPDH2 (0.64) NPSR1GPR84ALDH1A1IMPDH2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed